Hamilton12 Announces New Advisory Board Members
Hamilton12 today formally announced that Dr Michael Drew and Dr Adam Walk had become the latest additions to its advisory board. They join Associate Professor Tim Kastelle, who became the inaugural advisory board member in 2018.
"We are pleased to welcome Michael and Adam to our advisory board," said Co-Founder Dr Jason Hall. "With vast experience in investment governance, asset allocation, pension plan design, and outcome-oriented investing, Hamilton12 will benefit enormously from their insights and guidance as we market our first series of rules-based investable indices."
Dr Drew is a consulting financial economist whose research has appeared in leading practitioner journals, including the Journal of Pension Economics and Finance, the Journal of Portfolio Management, and the Journal of Retirement. He has been invited to make submissions and testify before numerous committees, including the U.S. Department of Labor and the U.S. Securities and Exchange Commission joint hearing on Target Date Funds, and the Productivity Commission hearing on Superannuation: Assessing Efficiency and Competitiveness. Michael is currently a Trustee Director and member of the investment committee of QSuper and a member of the investment advisory board of the sovereign wealth fund of Timor-Leste.
Dr Walk is a financial economist with 20 years' experience in investment, governance, and risk management. His current governance roles include being a trustee director and member of the Investment Committee at Rest, an advisor to the Group Capital and Investment Committee at RACQ, and a member of the Investment Committee at RSL Queensland. Dr Walk's research has been published in journals such as the Journal of Portfolio Management and the Journal of Retirement, and he co-authored (with Dr Michael Drew) a monograph entitled "Investment Governance for Fiduciaries" which was published by the CFA Institute Research Foundation in 2019.
"I am delighted to have joined the advisory board at Hamilton12 because I think that thoughtful innovation has great potential in improving outcomes for investors", said Dr Walk.
Dr Drew and Dr Walk join Associate Professor Tim Kastelle from the University of Queensland, who brings detailed experience in business model innovation, innovation systems and lean startup methodology. Tim has published widely in the leading innovation journals and is recognised globally as a leading expert in the field.
"We are privileged to have such a high level of experience within our advisory board, ready to strengthen our strategic positioning as we look to help institutional investors achieve better risk-adjusted returns at lower cost," said Dr Jason Hall. "We are excited to offer large asset owners a transparent and disciplined way to increase returns, minimise risk and reduce expenses on a persistent basis."